Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease Severities
收藏DataCite Commons2024-12-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006015/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The objective of the present Post Marketing Surveillance Study (PMS) study is to evaluate safety and effectiveness of tiotropium bromide (Spiriva®) 18 µg once daily in 5,000 patients with COPD of varying severities over 8 weeks.
提供机构：
Vivli
创建时间：
2020-09-02
